ECT Schizophrenia Serotonin Study

Serotonin Uptake to Lymphocytes and Citalopram Platelets Binding of Treatment-Resistant Schizophrenia Patients Before and After Electroconvulsive Therapy

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00278668

Enrollment

Registered

2006-01-18

Start date

2006-10-31

Completion date

2006-10-31

Last updated

2008-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Brief summary

We suggest to investigate serotonin uptake in schizophrenia patients receiving ECT

Detailed description

We suggest to investigate serotonin uptake in schizophrenia patients receiving ECT

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 55 Years

Healthy volunteers

Inclusion criteria

Participants must meet DSM-IV criteria for schizophrenia, as assessed by the Structured Clinical Interview - Patient Version (SCID) (First et al., 1995). Ages 18 -55 Men and/or women -

Exclusion criteria

1. History of neurological disorders, active substance abuse in the previous 3 months. 2. Estimated IQ less then 70. 3. SSRIs treatment 4 weeks prior to the study. 4. Any subject suffering from inflammatory fever disease will be excluded from the study. \-

Contacts

Primary ContactAvi Peled, MD

av_peled@netvision.net.il972522844050

Outcome results